These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 29197196)

  • 1. Analysis of the Prevalence of Mental Disorders in Psoriasis: The Relevance of Psychiatric Assessment in Dermatology.
    Ferreira BR; Pio-Abreu JL; Reis JP; Figueiredo A
    Psychiatr Danub; 2017 Dec; 29(4):401-406. PubMed ID: 29197196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatric morbidity in pemphigus and psoriasis: a comparative study from India.
    Kumar V; Mattoo SK; Handa S
    Asian J Psychiatr; 2013 Apr; 6(2):151-6. PubMed ID: 23466113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated prevalence of Type D (distressed) personality in moderate to severe psoriasis is associated with mood status and quality of life impairment: a comparative pilot study.
    Molina-Leyva A; Caparros-delMoral I; Ruiz-Carrascosa JC; Naranjo-Sintes R; Jimenez-Moleon JJ
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1710-7. PubMed ID: 25623927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis and Associated Psychiatric Disorders: A Systematic Review on Etiopathogenesis and Clinical Correlation.
    Ferreira BI; Abreu JL; Reis JP; Figueiredo AM
    J Clin Aesthet Dermatol; 2016 Jun; 9(6):36-43. PubMed ID: 27386050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased prevalence of psychiatric disorders and health care-associated costs among patients with moderate-to-severe psoriasis.
    Han C; Lofland JH; Zhao N; Schenkel B
    J Drugs Dermatol; 2011 Aug; 10(8):843-50. PubMed ID: 21818505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks of developing psychiatric disorders in pediatric patients with psoriasis.
    Kimball AB; Wu EQ; Guérin A; Yu AP; Tsaneva M; Gupta SR; Bao Y; Mulani PM
    J Am Acad Dermatol; 2012 Oct; 67(4):651-7.e1-2. PubMed ID: 22243764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric morbidity in patients with psoriasis.
    Singh SM; Narang T; Dogra S; Verma AK; Gupta S; Handa S
    Cutis; 2016 Feb; 97(2):107-12. PubMed ID: 26919499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychological Profile of Patients with Psoriasis.
    Lim DS; Bewley A; Oon HH
    Ann Acad Med Singap; 2018 Dec; 47(12):516-522. PubMed ID: 30636268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between psoriasis and mental illness: an update for clinicians.
    Hedemann TL; Liu X; Kang CN; Husain MI
    Gen Hosp Psychiatry; 2022; 75():30-37. PubMed ID: 35101785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alpha-interferon and mental disorders].
    Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
    Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differences in access to Internet and Internet-based information seeking according to the type of psychiatric disorder].
    Brunault P; Bray A; Rerolle C; Cognet S; Gaillard P; El-Hage W
    Rev Epidemiol Sante Publique; 2017 Apr; 65(2):125-136. PubMed ID: 28153646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ADH/D and impulsiveness: Prevalence of impulse control disorders and other comorbidities, in 81 adults with attention deficit/hyperactivity disorder (ADH/D)].
    Porteret R; Bouchez J; Baylé FJ; Varescon I
    Encephale; 2016 Apr; 42(2):130-7. PubMed ID: 26928277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriasis in Israel: demographic, epidemiology, and healthcare services utilization.
    Shalom G; Zisman D; Babaev M; Horev A; Tiosano S; Schonmann Y; Comaneshter D; Cohen AD
    Int J Dermatol; 2018 Sep; 57(9):1068-1074. PubMed ID: 29978903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidities and health-related quality of life in Spanish patients with moderate to severe psoriasis: a cross-sectional study (Arizona study).
    Sanchez-Carazo JL; López-Estebaranz JL; Guisado C
    J Dermatol; 2014 Aug; 41(8):673-8. PubMed ID: 24942203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychiatric morbidity in vitiligo and psoriasis: a comparative study from India.
    Mattoo SK; Handa S; Kaur I; Gupta N; Malhotra R
    J Dermatol; 2001 Aug; 28(8):424-32. PubMed ID: 11560159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PSYCHOPATHOLOGICAL DISORDERS AS COMORBIDITY IN PATIENTS WITH PSORIASIS (REVIEW).
    Bolotna L; Sarian O
    Georgian Med News; 2020 Apr; (301):143-147. PubMed ID: 32535579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of mental health comorbidity in psoriasis.
    Wu JJ; Feldman SR; Koo J; Marangell LB
    J Dermatolog Treat; 2018 Aug; 29(5):487-495. PubMed ID: 29057684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mental disorders in general hospital patients].
    Rothenhäusler HB
    Psychiatr Danub; 2006 Dec; 18(3-4):183-92. PubMed ID: 17099609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients.
    Carpentier PJ; Krabbe PF; van Gogh MT; Knapen LJ; Buitelaar JK; de Jong CA
    Am J Addict; 2009; 18(6):470-80. PubMed ID: 19874168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis and addiction: assessing mental health based on a cross-sectional study in Germany.
    Schielein MC; Tizek L; Knobloch L; Maaßen D; Biedermann T; Zink A
    Eur J Dermatol; 2021 Dec; 31(6):722-729. PubMed ID: 34726161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.